Stockholm Stock Exchange | Large Cap
Sobi
+16.18%
Latest
+5.15%
3 months
BarclaysExane BNP ParibasBerenbergDeutsche BankDNB CarnegiePareto SecuritiesNordeaRBCSEBJefferiesSEB EquitiesDNB MarketsKepler CheuvreuxNordea MarketsCarnegieMorgan StanleyHSBCRBC Capital MarketsDNBHandelsbanken Capital MarketsMorningstarDanske Bank MarketsDanske BankJefferies InternationalHandelsbankenABG Sundal Collier

About The Company

Swedish Orphan Biovitrum (Sobi) is a pharmaceutical company with two focus areas: haemophilia and rare diseases. Sobi is a merger of Swedish Orphan and Biovitrum. The company has its premises in Karolinska Institutet Science Park in Solna.
Wikipedia